Gene Therapy Strategies to Block HIV-1 Replication by RNA Interference

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)

Abstract

The cellular mechanism of RNA interference (RNAi) plays an antiviral role in many organisms and can be used for the development of therapeutic strategies against viral pathogens. Persistent infections like the one caused by the human immunodeficiency virus type 1 (HIV-1) likely require a durable gene therapy approach. The continuous expression of the inhibitory RNA molecules in T cells is needed to effectively block HIV-1 replication. We discuss here several issues, ranging from the choice of RNAi inhibitor and vector system, finding the best target in the HIV-1 RNA genome, alternatively by targeting host mRNAs that encode important viral cofactors, to the setup of appropriate preclinical test systems. Finally, we briefly discuss the relevance of this topic for other viral pathogens that cause a chronic infection in humans
Original languageEnglish
Pages (from-to)71-95
JournalAdvances in experimental medicine and biology
Volume848
DOIs
Publication statusPublished - 2015

Cite this